Israel’s Ministry of Economy and Industry has already reopened its anti-dumping investigation into Canadian medical cannabis, just a week after a procedural defect forced the same case to close.
Israel has seemingly followed in the footsteps of its US ally this week after announcing plans to impose 165% tariffs on cannabis imports from Canada.
The Canadian Cannabis Council (C3) has pushed back on Israel’s continued claims of ‘product dumping’, in the latest escalation of a contentious trade dispute.
Canadian medical cannabis imports in Israel could now face tariffs of up to 175% amid the latest escalation of a dispute over allegations of ‘product dumping’.
The head of the Canadian Cannabis Council (C3) has said he is ‘severely disappointed’ with Israel’s preliminary decision to tax Canadian cannabis imports.
Germany’s CanG bill looks to be back on track Germany’s landmark CanG bill is now expected to pass through the Federal Parliament (Bundestag) this month, putting it back on track to come into effect by April 1.
Israel could soon see a dramatic increase in the number of medical cannabis patients as the government publishes proposals for sweeping reforms aimed at streamlining access.
IM Cannabis [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”IMCC” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] International medical cannabis operator IM Cannabis has now received its second warning from NASDAQ regarding its share price, months after pushing through a share price consolidation to remain on the exchange.
As reported by the Israeli Cannabis Magazine Dozens of employees of the long-standing cannabis company Tikun Olam will be laid off after the company decided to close the cultivation activity on its two farms in Kfar Yehoshua and in Benaot HaKar.
